Edition:
United Kingdom

Solasia Pharma KK (4597.T)

4597.T on Tokyo Stock Exchange

390JPY
19 Jan 2018
Change (% chg)

¥6 (+1.56%)
Prev Close
¥384
Open
¥384
Day's High
¥402
Day's Low
¥383
Volume
2,918,800
Avg. Vol
5,160,253
52-wk High
¥652
52-wk Low
¥219

Chart for

About

Solasia Pharma KK is a Japan-based pharmaceutical company. The Company is mainly engaged in the development, sale, importing and exporting of pharmaceutical products targeting commercialization in Japan, China and other Asian countries. It focuses on commercializing assets in the oncology/hematology field, by developing products... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): ¥29,134.29
Shares Outstanding(Mil.): 87.75
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Pledpharma and Solasia enter license agreement on Pledox in Asia

* PLEDPHARMA AND SOLASIA ENTER LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE PLEDOX® IN ASIA

20 Nov 2017

BRIEF- Solasia Pharma to sign distributorship agreement with ITOCHU

* Says it plans to sign a distributorship agreement with ITOCHU Corp, regarding sales of the company's products in China (except Hong Kong and Macau )

13 Sep 2017

Earnings vs. Estimates